Notice Number: NOT-DA-14-008

Key Dates
Release Date: March 5, 2014

Issued by
National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to inform potential applicants of the National Institute on Drug Abuse's participation, effective immediately, in RFA-HG-14-020 "Development of Software and Analysis Methods for Biomedical Big Data in Targeted Areas of High Need (U01)."

The following sections of RFA-HG-14-020 have been updated to reflect the participation of NIDA iin this FOA.

Part 1. Overview Information

Components of Participating Organizations
National Human Genome Research Institute (NHGRI)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Drug Abuse (NIDA)
National Institute on Deafness and Other Communication Disorders (NIDCD)
National Institute of Mental Health (NIMH)
National Institute of Neurological Disorders and Stroke (NINDS)
National Library of Medicine (NLM)
Office of Strategic Coordination (Common Fund)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.172; 93.846; 93.242; 93.279, 93.853; 93.173; 93.856; 93.855; 93.879; 93.310

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Joni Rutter, Ph.D.
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0298
Email: jrutter@nida.nih.gov